Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 3/20 | 0.47 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.47 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.44 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.44 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.44 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.44 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.44 |
| ▸ | FAP | Q12884 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | PPARG | P37231 | 1/20 | 0.43 |
| ▸ | PPARA | Q07869 | 1/20 | 0.43 |
| ▸ | CPA3 | P15088 | 1/20 | 0.42 |
| ▸ | ANPEP | P15144 | 3/20 | 0.42 |
| ▸ | ENPEP | Q07075 | 3/20 | 0.42 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5340826 | 0.86 | S1PR2 (0.54) | S1PR2S1PR1S1PR3ALDH1A1ANPEP | |
| SCHEMBL29478407 | 0.83 | DPP4 (0.56) | DPP4DPP7S1PR2S1PR1DPP8 | |
| SCHEMBL2029955 | 0.83 | DPP4 (0.56) | DPP4DPP7S1PR2S1PR1DPP8 | |
| SCHEMBL975050 | 0.83 | DPP4 (0.56) | DPP4DPP7S1PR2S1PR1DPP8 | |
| SCHEMBL29478392 | 0.83 | DPP4 (0.56) | DPP4DPP7S1PR2S1PR1DPP8 | |
| SCHEMBL975049 | 0.83 | DPP4 (0.56) | DPP4DPP7S1PR2S1PR1DPP8 | |
| SCHEMBL288446 | 0.82 | CYP1A2 (0.44) | S1PR2S1PR1S1PR3ALDH1A1CYP1A2 | |
| SCHEMBL12475374 | 0.82 | AKR1B1 (0.52) | S1PR2S1PR1S1PR3ALDH1A1CYP1A2 | |
| SCHEMBL27999551 | 0.82 | CYP1A2 (0.44) | S1PR2S1PR1S1PR3ALDH1A1CYP1A2 | |
| SCHEMBL289226 | 0.81 | FOLH1 (0.45) | DPP4S1PR2S1PR1S1PR3DPP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070258899-A1 | Diagnostic and therapeutic agents | KARYON-CTT LTD (FI) | 2007-11-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070258899-A1 | Diagnostic and therapeutic agents | YBX1, MLX, TPX2 | DPP4 3194/4885DPP7 3508/4885S1PR2 1899/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.